In nasopharyngeal carcinoma, loss of CRIP2 promotes tumorigenesis and angiogenesis by interacting with NF-κB/p65 and compromises NF-κB-mediated proangiogenic cytokine expression including IL6, IL8, and VEGF44. This evidence concerns the gene CRIP2 and nasopharyngeal carcinoma.